Aequus Pharmaceuticals (Aequus Pharmaceuticals) Receivables Turnover : 0.07 (As of Sep. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Aequus Pharmaceuticals Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Aequus Pharmaceuticals's Revenue for the three months ended in Sep. 2023 was $0.01 Mil. Aequus Pharmaceuticals's average Accounts Receivable for the three months ended in Sep. 2023 was $0.14 Mil. Hence, Aequus Pharmaceuticals's Receivables Turnover for the three months ended in Sep. 2023 was 0.07.

Aequus Pharmaceuticals Receivables Turnover Historical Data

The historical data trend for Aequus Pharmaceuticals's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aequus Pharmaceuticals Receivables Turnover Chart

Aequus Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Receivables Turnover

Get a 7-Day Free Trial

2.38

2.57

3.93

3.16

2.11

Aequus Pharmaceuticals Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Sep23
Receivables Turnover	Get a 7-Day Free Trial															0.51	1.22	1.19	1.30	0.07

Competitive Comparison of Aequus Pharmaceuticals's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Aequus Pharmaceuticals's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aequus Pharmaceuticals's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aequus Pharmaceuticals's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Aequus Pharmaceuticals's Receivables Turnover falls into.

Aequus Pharmaceuticals Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Aequus Pharmaceuticals's Receivables Turnover for the fiscal year that ended in Dec. 2022 is calculated as

	Receivables Turnover (A: Dec. 2022 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2022 )	/ (	(Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )
=	1.016	/ (	(0.735	+	0.228)	/	2 )
=	1.016	/	0.4815
=	2.11

Aequus Pharmaceuticals's Receivables Turnover for the quarter that ended in Sep. 2023 is calculated as

	Receivables Turnover (Q: Sep. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Sep. 2023 )	/ (	(Accounts Receivable (Q: Dec. 2022 )	+	Accounts Receivable (Q: Sep. 2023 ))	/	count )
=	0.01	/ (	(0.228	+	0.052)	/	2 )
=	0.01	/	0.14
=	0.07

Aequus Pharmaceuticals (OTCPK:AQSZF) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Aequus Pharmaceuticals Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Aequus Pharmaceuticals's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Aequus Pharmaceuticals (Aequus Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aequus Pharmaceuticals Inc (OTCPK:AQSZF) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

AEQ:Germany AQS:Canada

Address

200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4

Website

https://www.aequuspharma.ca

Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.